CUBIST PHARMACEUTICALS INC Net Cash Provided by (Used in) Continuing Operations
CUBIST PHARMACEUTICALS INC reported Net Cash Provided by (Used in) Continuing Operations of $11.14 million for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-02.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NetCashProvidedByUsedInContinuingOperations · last filed 2014-05-02
- CUBIST PHARMACEUTICALS INC net cash provided by (used in) continuing operations for the quarter ending 2014-03-31 was $11.14M.
- CUBIST PHARMACEUTICALS INC net cash provided by (used in) continuing operations for the quarter ending 2013-12-31 was -$447.52M, a 1016.60% decline year-over-year.
- CUBIST PHARMACEUTICALS INC net cash provided by (used in) continuing operations for the quarter ending 2013-09-30 was $333.07M.
- CUBIST PHARMACEUTICALS INC net cash provided by (used in) continuing operations for the quarter ending 2013-06-30 was $142.43M.
- CUBIST PHARMACEUTICALS INC net cash provided by (used in) continuing operations for fiscal 2013 was -$13.06M.
- CUBIST PHARMACEUTICALS INC net cash provided by (used in) continuing operations for fiscal 2012 was -$93.58M.
- CUBIST PHARMACEUTICALS INC net cash provided by (used in) continuing operations for fiscal 2011 was -$176.34M, a 182.11% decline from fiscal 2010.
- CUBIST PHARMACEUTICALS INC net cash provided by (used in) continuing operations for fiscal 2010 was $214.76M.
| Period end | Net Cash Provided by (Used in) Continuing Operations 3 month | Net Cash Provided by (Used in) Continuing Operations 6 month | Net Cash Provided by (Used in) Continuing Operations 9 month | Net Cash Provided by (Used in) Continuing Operations 12 month |
|---|---|---|---|---|
| 2014-03-31 | $11.14M 10-Q · filed 2014-05-02 | -$436.38M derived: sum of 2 quarters · filed 2014-05-02 | -$103.31M derived: sum of 3 quarters · filed 2014-05-02 | $39.12M derived: sum of 4 quarters · filed 2014-05-02 |
| 2013-12-31 | -$447.52M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | -$114.45M derived: sum of 2 quarters · filed 2014-02-25 | $27.98M derived: sum of 3 quarters · filed 2014-02-25 | -$13.06M 10-K · filed 2014-02-25 |
| 2013-09-30 | $333.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $475.50M derived: sum of 2 quarters · filed 2013-11-12 | $434.46M 10-Q · filed 2013-11-12 | $483.29M derived: sum of 4 quarters · filed 2014-05-02 |
| 2013-06-30 | $142.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $101.39M 10-Q · filed 2013-08-06 | $150.22M derived: sum of 3 quarters · filed 2014-05-02 | $70.77M derived: sum of 4 quarters · filed 2014-05-02 |
| 2013-03-31 | -$41.03M 10-Q · filed 2014-05-02 | $7.79M derived: sum of 2 quarters · filed 2014-05-02 | -$71.66M derived: sum of 3 quarters · filed 2014-05-02 | -$104.29M derived: sum of 4 quarters · filed 2014-05-02 |
| 2012-12-31 | $48.82M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | -$30.62M derived: sum of 2 quarters · filed 2014-02-25 | -$63.26M derived: sum of 3 quarters · filed 2014-02-25 | -$93.58M 10-K · filed 2014-02-25 |
| 2012-09-30 | -$79.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$112.08M derived: sum of 2 quarters · filed 2013-11-12 | -$142.40M 10-Q · filed 2013-11-12 | -$169.23M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-06-30 | -$32.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | -$62.95M 10-Q · filed 2013-08-06 | -$89.78M derived: sum of 3 quarters · filed 2014-02-25 | -$236.23M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-03-31 | -$30.32M 10-Q · filed 2013-05-07 | -$57.15M derived: sum of 2 quarters · filed 2014-02-25 | -$203.59M derived: sum of 3 quarters · filed 2014-02-25 | -$166.57M derived: sum of 4 quarters · filed 2014-02-25 |
| 2011-12-31 | -$26.83M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | -$173.28M derived: sum of 2 quarters · filed 2014-02-25 | -$136.26M derived: sum of 3 quarters · filed 2014-02-25 | -$176.34M 10-K · filed 2014-02-25 |
| 2011-09-30 | -$146.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05 | -$109.43M derived: sum of 2 quarters · filed 2012-11-05 | -$149.50M 10-Q · filed 2012-11-05 | $51.49M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-06-30 | $37.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | -$3.06M 10-Q · filed 2012-08-07 | $197.94M derived: sum of 3 quarters · filed 2013-02-27 | |
| 2011-03-31 | -$40.08M 10-Q · filed 2012-05-01 | $160.92M derived: sum of 2 quarters · filed 2013-02-27 | ||
| 2010-12-31 | $201.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $214.76M 10-K · filed 2013-02-27 | ||
| 2010-09-30 | $13.77M 10-Q · filed 2011-11-02 | |||
| 2009-12-31 | -$251.47M 10-K · filed 2012-02-27 |